bb wrote:
medlife wrote:
Hahaha, definitely not excusing their behavior in this year's rankings! I was just looking historically, they seem to be clear #3 and still with a distinct gap above B/K/S/C. Their PE/VC placement in 2020 is 15% (vs. HBS's 22%). The next is Booth at 9%, Sloan/CBS at 5-6%. So there's still some advantage for W over the other M7s. Similarly, saw a Crunchbase article pop up recently where H/S obviously led in # of startups, but Wharton still had 2x number of startups as the next M7 (after accounting for class size).
This comment might ruffle some feathers from the other M7 supporters..
I can totally see it. There is the H and S rivalry and W has been bundled with them. Years ago it's been HBS vs. alt GSB for those who preferred the west coast and then Wharton for finance-focus. This is years ago and it stuck. Now Wharton is no longer a finance-only school and HBS is #5 or 6 in the rankings. But I don't see Wharton dislodging Harvard or Stanford any time soon. And Harvard does not seem to really care about the rankings. Here is something to lighten up the conversation:
https://gmatclub.com/forum/real-busines ... 78619.htmlExcellent post. please I need your opinion on which school to pick. I just got accepted into the MBA program at Mercer UNiversity, Atlanta and Temple University Fox School of Business, Pennsylvania . They both have a Health Management specialization which is what I am going for. But I dont know which one to pick. WHich one do you think employers would view as better? Thanks